Abstract
Background
The efficacy of antiretroviral therapy has made HIV a chronic condition. The prevalence of obesity in HIV positive patients has subsequently risen and is present in 6–34% of men and 21–30% of women (Keithley et al. J Assoc Nurses AIDS Care 20(4):260–74, 2009). Sleeve gastrectomy is a safe and effective procedure for weight loss in the general population, but having HIV may bring hesitation to performing bariatric surgery for some practitioners.
Objectives
The aim of this study is to evaluate the safety and efficacy of laparoscopic sleeve gastrectomy (LSG) in patients with HIV.
Methods
A retrospective analysis of prospectively collected data of patients with HIV who underwent LSG at a community hospital by a single surgeon was performed. Nine patients with HIV underwent LSG. Primary outcomes include weight loss at 6 and 12 months and postoperative CD4 count and viral load. Secondary outcomes include alteration to antiretroviral therapy (ART).
Results
Our patients had a mean BMI of 46 (range 35–66) and were all well controlled on ART preoperatively. Mean weight loss at 12 months was 40 kg (range 21–55), with mean excess body weight loss 69% (range 42–112). There were no significant changes in CD4 counts, and all patients continued to have undetectable viral loads at 1 year postoperatively. One patient had a change in ART, which was unrelated to bariatric surgery. There were no complications in our patient group.
Conclusion
This is the largest series to date evaluating sleeve gastrectomy in HIV-positive patients and further supports the safety and efficacy of sleeve gastrectomy in this patient population.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Damouche A, Lazure T, Avettand-Fenoel V, et al. Adipose tissue is a neglected viral reservoir and an inflammatory site during chronic HIV and SIV infection. PLoS Pathog. 2015;11:e1005153.
Willson T, Gomberawalla A, Maloney K, et al. Factors influencing 30-day emergency visits and readmissions after sleeve gastrectomy: results from a community bariatric center. Obes Surg. 2015 Jun;25(6):975–81.
Fysekidis M, Cohen R, Bekheit M, et al. Sleeve gastrectomy is a safe and efficient procedure in HIV patients with morbid obesity: a case series with results in weight loss, comorbidity evolution, CD4 count, and viral load. Obes Surg. 2015;25:229–33.
Eddy F, Elvin S, Sanmani L. Bariatric surgery: an HIV-positive patient’s successful journey. Int Journal STD & AIDS. 2016;27(1):70–1.
Selke H, Norris S, Osterholzer D, et al. Bariatric surgery outcomes in HIV-infected subjects: a case series. AIDS Patient Care STDs. 2010;24:545–50.
Fazylov R, Soto E, Merola S, et al. Laparoscopic gastric bypass surgery in human immunodeficiency virus-infection patients. Surg Obes Relat Dis. 2007;3:637–9.
Cabrero E, Griffin L, Burgos A. Prevalence and impact of body physical changes in HIV patients treated with highly active antiretroviral therapy: results from a study on patient and physician perceptions. AIDS Patient Care STDs. 2010;24(1):5–13.
Horberg M, Hurley L, Klein D, et al. Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Arch Surg. 2006;141:1238–45.
Lima VD, Harrigan R, Murray M, et al. Differential impact of adherence on long-term treatment response among naïve HIV-infected individuals. AIDS. 2008;22:2371–80.
Nyberg C, Patterson B, Williams M. When patients cannot take pills: antiretroviral drug formulations for managing adult HIV infection. Topics in Antiviral Med. 2011;19(3):126–31.
Muzard L, Alvarez JC, Gbedo C, et al. (2016). Tenofovir pharmacokinetic after sleeve gastrectomy in four severely obese patients living with HIV. Obese Res Cin Pract. doi:10.1016/j.orcp.2016.06.004.
Zivich S, Cauterucci M, Allen S, et al. Long-term virologic outcomes following bariatric surgery in patients with HIV. Obes Res Clin Pract. 2015;9(6):633–5.
Seeley RJ, Chambers AP, Sandoval DA. The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes. Cell Metab. 2015;21:369–78.
Keithley JK, Duloy AM, Swanson B, et al. HIV infection and obesity: a review of the evidence. J Assoc Nurses AIDS Care. 2009;20(4):260–74.
Acknowledgements
None
Funding
No funding provided
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Dr. Panko has no disclosures.
Dr. Dunford has no disclosures.
Dr. Lutfi: consultant for Gore, Ethicon
Rights and permissions
About this article
Cite this article
Panko, N., Dunford, G. & Lutfi, R. HIV Infection Is Not a Contraindication to Laparoscopic Sleeve Gastrectomy for Morbid Obesity. OBES SURG 28, 464–468 (2018). https://doi.org/10.1007/s11695-017-2865-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-017-2865-5